Transcode Therapeutics Inc
Change company Symbol lookup
Select an option...
RNAZ Transcode Therapeutics Inc
IRM Iron Mountain Inc
BKU BankUnited Inc
TGB Taseko Mines Ltd
AB AllianceBernstein Holding LP
LIQT LiqTech International Inc
ITCI Intra-Cellular Therapies Inc
OPBK OP Bancorp
LUVU Luvu Brands Inc
FINV FinVolution Group
Go

Health Care : Biotechnology |
Company profile

TransCode Therapeutics, Inc. is a ribonucleic acid (RNA) oncology company. The Company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer. TTX-MC138 comprises proprietary iron-oxide nanoparticles and oligonucleotides that specifically target microRNA-10b. The nanoparticles serve as the vehicle to deliver oligonucleotides to metastatic cancer cells. The magnetic properties of these nanoparticles allow for monitoring of their delivery using non-invasive imaging. Its pipeline products also include TTX-siPDL1, TTX-siLIN28b and TTX-RIGA. TTX-siPDL1 is a checkpoint inhibitor targeting programmed cell death protein ligand 1 (PD-L1). TTX-RIGA utilizes its delivery system and is intended to activate the RIG-I signaling pathway to elicit an immune response to eliminate and/or reduce the risk of developing disorders associated with abnormal apoptotic or differentiative processes, by triggering an immune response that targets developing cancer cells.

Closing Price
$2.92
Day's Change
0.23 (8.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.99
Day's Low
2.71
Volume
(Above Average)
Volume:
88,385

10-day average volume:
79,368
88,385

Microsoft stock rises 0.5% toward 3rd straight record close, as market cap tops $2.5 trillion

2:42 pm ET November 4, 2021 (MarketWatch)
Print
	

(END) Dow Jones Newswires

November 04, 2021 14:42 ET (18:42 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.